Search
Drug Discovery & Development
- Pascal Kraft
- Jan 31, 2023
- 1 min read
Updated: Feb 6, 2023
Ymmunobio get ownership rights to NPTXR antibodies. Read more here:
Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Comments